Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #389960 on Innovation Pharmaceuticals Inc (IPIX)
loanranger
05/27/22 3:51 PM
#389961 RE: frenchbroad #389960
CallMeCrazy
05/28/22 1:15 PM
#389982 RE: frenchbroad #389960
Large pharmaceutical companies are acquiring smaller entrants with novel antibiotics. The trend is expected to shape the future of the market.
The two final-phase studies of etrasimod are the first to read out after Pfizer closed its Arena buyout in March. After 12 weeks of taking etrasimod, 27% of patients with moderately to severely active ulcerative colitis entered remission. That compares with just 7.4% of patients who received a placebo. After a year, almost a third of patients were in remission, 32.1%, vs. 6.7% of those in the placebo group.
I was invested in $ARNA Arena Pharmaceuticals for 7 years of crazy ups and downs. The CEO was a slime ball but they had some outstanding drugs in Phase 2 and 3. It was recently Bought out basically for 1 drug in Phase 3 trials. It wasn’t even approved, it just showed its phase 3 results which were outstanding. Pfizer bought the company for SEVEN Billion FOR ONE DRUG...